Lupin Secures FDA Approval for Colonoscopy Preparation Drug with 180-Day Exclusivity
Pharmaceutical giant Lupin Limited announced on Tuesday that it has received formal approval from the United States Food and Drug Administration (US FDA) for its abbreviated new drug application (ANDA) for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride tablets. The approval grants the Mumbai-based company a significant competitive advantage in the U.S. market, specifically securing…
